📖+10 XP
🎧+10 XP
✅+15 XP
Level A1 – BeginnerCEFR A1
2 min
77 words
- Tuberculosis is a deadly infectious disease that kills many people.
- Doctors often treat tuberculosis with the antibiotic rifampicin daily.
- Some bacteria have become resistant to rifampicin in many places.
- Scientists tested rifampicin together with a second new compound.
- The second compound attacks the bacteria in a different way.
- In laboratory tests the drug pair killed resistant bacteria.
- In an animal model the two drugs worked much better.
- Researchers plan to make a stable medicine from the probe.
Difficult words
- tuberculosis — A serious disease that affects the lungs.
- infectious — Can spread from one person to another.
- antibiotic — A medicine that kills bacteria and stops infections.
- resistant — Not killed by a medicine or treatment.
- compound — A chemical substance made for research or medicine.
- laboratory — A room where scientists do tests and experiments.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you ever taken antibiotics?
- Do you know the name of any antibiotic medicine?
- Would you like to work in a laboratory?
Related articles
31 Dec 2025
New modular CAR-T system controls where and when cells attack
Researchers at the University of Chicago created GA1CAR, a modular CAR-T system that uses short-lived Fab fragments to guide and pause tumor targeting. In animal tests the same cells were redirected to different tumors and remained functional.
5 Dec 2025
2 Oct 2025
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
16 Oct 2024
19 Sept 2025